Jae‐Joon Yim

23.4k total citations · 2 hit papers
384 papers, 13.1k citations indexed

About

Jae‐Joon Yim is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jae‐Joon Yim has authored 384 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 181 papers in Epidemiology, 167 papers in Infectious Diseases and 100 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jae‐Joon Yim's work include Tuberculosis Research and Epidemiology (157 papers), Mycobacterium research and diagnosis (115 papers) and Infectious Diseases and Tuberculosis (46 papers). Jae‐Joon Yim is often cited by papers focused on Tuberculosis Research and Epidemiology (157 papers), Mycobacterium research and diagnosis (115 papers) and Infectious Diseases and Tuberculosis (46 papers). Jae‐Joon Yim collaborates with scholars based in South Korea, Ethiopia and United States. Jae‐Joon Yim's co-authors include Jaekwang Kim, Sung Koo Han, Chiyoung Ahn, Olof Rådmark, Patrick Provost, V. Narry Kim, Junho Lee, Jinju Han, Sunyoung Kim and Chang‐Hoon Lee and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Jae‐Joon Yim

367 papers receiving 12.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The nuclear RNase III Drosha initiates microRNA processing

2003 3.9k citations Jae‐Joon Yim et al. profile →
Development and Validation of a Deep Learning–Based Automated Detection Algorithm for Major Thoracic Diseases on Chest Radiographs

2019 289 citations Jae‐Joon Yim, Chang Min Park et al. profile →

Peers

Countries citing papers authored by Jae‐Joon Yim

Since Specialization

Citations

This map shows the geographic impact of Jae‐Joon Yim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jae‐Joon Yim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jae‐Joon Yim more than expected).

Fields of papers citing papers by Jae‐Joon Yim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jae‐Joon Yim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jae‐Joon Yim. The network helps show where Jae‐Joon Yim may publish in the future.

Co-authorship network of co-authors of Jae‐Joon Yim

This figure shows the co-authorship network connecting the top 25 collaborators of Jae‐Joon Yim. A scholar is included among the top collaborators of Jae‐Joon Yim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jae‐Joon Yim. Jae‐Joon Yim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	VLX600, an anticancer iron chelator, exerts antimicrobial effects on Mycobacterium abscessus infections 2025 ·Microbiology Spectrum ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ju Young Lee, (unknown), Jae‐Joon Yim, Nakwon Kwak, Bum‐Joon Kim	0
2	Secreted Chorismate Mutase: A Novel Prognostic Factor in Mycobacterium intracellulare Pulmonary Disease 2025 ·The Journal of Infectious Diseases ·(unknown), Ju Young Lee, (unknown), Jake Whang, (unknown), Jae‐Joon Yim, Bum‐Joon Kim, Nakwon Kwak	0
3	High-Dose Rifampicin for 3 Months after Culture Conversion for Drug-Susceptible Pulmonary Tuberculosis 2024 ·Tuberculosis & respiratory diseases ·Nakwon Kwak, (unknown), Hyung Jun Kim, (unknown), Jae Ho Lee, Jeongha Mok, Yong Soo Kwon, Young Ae Kang, Youngmok Park, Ji Yeon Lee, Doosoo Jeon, Jung‐Kyu Lee, (unknown), Jake Whang, (unknown), Young Ran Kim, (unknown), Jiwon Park, Seokyung Hahn, Jae‐Joon Yim	1
4	Subtyping of Performance Trajectory During Medical School, Medical Internship, and the First Year of Residency in Training Physicians: A Longitudinal Cohort Study 2024 ·Journal of Korean Medical Science ·Je‐Yeon Yun, Hyunjin Ryu, Ju Whi Kim, Hyun Bae Yoon, Seung W. Choi, Wan Beom Park, Eun Jung Bae, Jae‐Joon Yim, Sun Jung Myung	1
5	Metabolomic Characteristics of Nontuberculous Mycobacterial Pulmonary Disease 2024 ·The Journal of Infectious Diseases ·Jung-Eun Kim, (unknown), (unknown), Jae‐Joon Yim, Joo‐Youn Cho, Nakwon Kwak	4
6	Rates and Risk Factors of Progression in Patients With Nontuberculous Mycobacterial Pulmonary Disease 2024 ·CHEST Journal ·(unknown), Sung A Kim, (unknown), Nakwon Kwak, Jae‐Joon Yim	4
7	Fecal and Sputum Microbiota and Treatment Response in Patients With Mycobacterium abscessus Pulmonary Disease 2024 ·The Journal of Infectious Diseases ·(unknown), (unknown), So Yeon Kim, (unknown), Yong‐Joon Cho, Nakwon Kwak, Dong-Hyun Kim, Jae‐Joon Yim	2
8	Ethical Issues Referred to Clinical Ethics Support at a University Hospital in Korea: Three-Year Experience After Enforcement of Life-Sustaining Treatment Decisions Act 2023 ·Journal of Korean Medical Science ·Shin Hye Yoo, Yejin Kim, (unknown), (unknown), Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Jae‐Joon Yim	3
9	The Association Between Bacille Calmette-Guérin Vaccination and Nontuberculous Mycobacterial Pulmonary Disease 2022 ·Journal of Korean Medical Science ·Nakwon Kwak, (unknown), Hyung‐Jun Kim, Hyun Woo Lee, Jae‐Joon Yim, Chang‐Hoon Lee	2
10	Treatment outcome of continuation of intravenous amikacin for Mycobacterium abscessus pulmonary disease with a persistent culture positivity after the treatment initiation 2022 ·Journal of Infection and Chemotherapy ·(unknown), Seo Young Park, Byung Woo Jhun, Youngmok Park, Young Ae Kang, Jimyung Park, Nakwon Kwak, Jae‐Joon Yim, Tae Sun Shim, Kyung‐Wook Jo	4
11	Determination of Clinical Characteristics of Mycobacterium kansasii-Derived Species by Reanalysis of Isolates Formerly Reported as M. kansasii 2021 ·Annals of Laboratory Medicine ·Young‐Gon Kim, Hong Yeul Lee, Nakwon Kwak, Jae Hyeon Park, Taek Soo Kim, Man Jin Kim, (unknown), Sung Sup Park, Jae‐Joon Yim, Moon‐Woo Seong	3
12	A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic 2021 ·Scientific Reports ·Hyung‐Jun Kim, (unknown), Hyunsook Hong, Jae‐Joon Yim, Jinwoo Lee	25
13	Protocol of a Nationwide Observational Study among Patients with Nontuberculous Mycobacterium Pulmonary Disease in South Korea (NTM-KOREA) 2020 ·Tuberculosis & respiratory diseases ·Nakwon Kwak, Hongjo Choi, Doosoo Jeon, Byung Woo Jhun, Kyung‐Wook Jo, Young Ae Kang, Yong Soo Kwon, Myungsun Lee, Jeongha Mok, Tae Sun Shim, Hong‐Joon Shin, Jake Whang, Jae‐Joon Yim	5
14	Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients 2018 ·American Journal of Respiratory and Critical Care Medicine ·David E. Griffith, Gina Eagle, Rachel Thomson, Timothy R. Aksamit, Noriko Hasegawa, (unknown), Doreen Addrizzo‐Harris, Anne E. O’Donnell, Theodore K. Marras, Patrick A. Flume, Michael R. Loebinger, Lucy Morgan, Paola Castellotti, A. T. Hill, Stephen J. Ruoss, Jae‐Joon Yim, Felix C. Ringshausen, Stephen K. Field, James Nezamis, Kevin Winthrop	1
15	Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense 2016 ·Clinical Infectious Diseases ·Jimyung Park, Jaeyoung Cho, Chang‐Hoon Lee, Sung Koo Han, Jae‐Joon Yim	101
16	Inhaled Corticosteroids Use Is Not Associated With an Increased Risk of Pregnancy-Induced Hypertension and Gestational Diabetes Mellitus 2016 ·Medicine ·Chang‐Hoon Lee, (unknown), Eun Jin Jang, Joon Ho Lee, Yun Jung Kim, (unknown), Deog Kyeom Kim, Jae‐Joon Yim, Ho Il Yoon	6
17	A comparative structural analysis of sepiapterin reductase from Drosophila by homology modeling 2015 ·SHILAP Revista de lepidopterología ·Kiyoung Kim, Keon‐Hyoung Song, Jae‐Joon Yim	2
18	Isolation of multiple nontuberculous mycobacteria species in the same patients 2011 ·International Journal of Infectious Diseases ·Hyo-Jeong Lim, Chang Min Park, (unknown), Jinwoo Lee, Sang‐Min Lee, Seok‐Chul Yang, Chul‐Gyu Yoo, (unknown), Sung Koo Han, Jae‐Joon Yim	22
19	The F-actin-microtubule crosslinker Shot is a platform for Krasavietz-mediated translational regulation of midline axon repulsion 2007 ·Development ·Seongsoo Lee, Minyeop Nahm, Mihye Lee, Minjae Kwon, (unknown), Alireza Dehghani Zadeh, Hanwei Cao, Hyungjun Kim, Zang Hee Lee, Seog Bae Oh, Jae‐Joon Yim, Peter A. Kolodziej, Seungbok Lee	57
20	Biosynthetic Enzymes of Tetrahydrolimipterin from Green Sulfur Bacterium Chlorobium Limicola 1998 ·Pteridines ·Dongmin Kang, Sang‐Joon Kim, Jae‐Joon Yim	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact